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Abstract 
The release rate of an active pharmaceutical ingredient (API) from a dosage form, measured by a dissolution test, is 
one of the key parameters governing the formulation viability. A number of dissolution tests have to be performed 
during the life cycle of a dosage form. This number can be significantly reduced by prediction of the API dissolution 
behavior. Thus the aim of this work was to find if, and how precisely, it is possible to predict dissolution behavior of 
final dosage forms by carrying out the experiments with their precursors. In this purpose the rate of release of a model 
API – caffeine –from a powdered, granulated and compacted form was observed. The experiments were performed in 
a flow-through cell dissolution apparatus (USP 4) with agglomerates and in a paddle dissolution apparatus (USP 2) 
with tablets and capsules. It was found that the caffeine release from the agglomerates was retarded by the excipient 
matrix and that compacted caffeine dissolved faster than granulated caffeine. However, the dissolution profiles were 
changed when model forms were compressed and then ground up. Consequently, the release rate of the granulated 
caffeine exceeded the release rate of the compacted form. Facts which were found during the measurement of the 
agglomerates and final dosage forms were in compliance, hence it was shown that dissolution behavior of final 
dosage forms can be predicted from their precursors. 
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1. Introduction 
The release rate of an active ingredient from the dosage form is one of the key parameters governing 
the formulation viability. It may be affected by various factors that were summarized by Banakar [1] into 
six main classes; i.e. factors related to the physicochemical properties of the drug, to the drug product 
formulation, to the dosage form, to the dissolution testing device, to the dissolution test parameters and 
miscellaneous factors. However, this classification is oversimplified for the understanding the influence of 
these factors on the API dissolution rate, as more than one factor is usually involved in the process. 
Authors of dissolution studies face this problem with keeping some of these parameters constant. Then 
they can be focused on a particular class of parameters or on a particular procedure, which affects API 
dissolution rate. A typical example of such approach is the work of the founder of drug dissolution testing, 
G. Levy [2]. In his work he presents dissolution experiments of tablets with the same API (constant 
physicochemical properties of the drug) under constant conditions, but with different formulation 
(excipient content) or with different factors related to dosage form (granule size, precompression 
pressure). The research on factors affecting the rate of API release was typical in sixties and seventies. 
The most important works can be found in ref. [3]. These works established a basis for authors dealing 
with the prediction of a dissolution behavior.  
Authors of predictive dissolution studies are usually concerned with in vitro/in vivo correlations mainly 
of controlled release formulations, eg. [4-6], which is not so surprising as these formulations can bring 
serious problems, if they are not absorbed properly in gastrointestinal tract. Thus the prediction of the 
final dosage forms dissolution behavior from its precursors, as other predictive studies, is not of the most 
interest, although such knowledge can be very useful for pharmaceutical manufacturers. It could help 
avoiding the necessity to always carry out experiments with all candidates on the dosage form during its 
development or if some changes were (or should be) made in processing of the dosage form. Instead, 
some candidates could be removed already in the stage of their precursors and only the most promising 
candidates can continue to following development and consequently to further dissolution studies.  
A similar approach, that we think is useful, can be found in very promising works of Jia and Williams 
[7] as well as of Stepanek [8], in which they simulated dissolution of tablets or granules with specific 
properties. Their works bring certainly facilitation of the dosage form development, but we miss some 
correlation between behavior of granule and tablet or capsule. Moreover these works cannot cover all 
interactions that can occur between the active ingredient and excipients. 
Therefore we decided to investigate, if there is any correlation between agglomerates and final dosage 
forms. For that purpose, we conducted experiments using different agglomerates and different final 
dosage forms. The dissolution experiments of agglomerates were performed in USP 4 apparatus, as it 
provides very reliable and reproducible results suitable for distinguishing differences between individual 
forms [9], which we also wanted to find out. The dissolution experiments of final dosage forms were 
performed in USP 2 apparatus, as it is still the most common apparatus employed in the pharmaceutical 
industry. 
 
Nomenclature 
 
A surface of particles, m2 
c concentration, kg m-3 
Cs saturated concentration, kg m-3 
D diffusion coefficient, m2 s-1 
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Def effective diffusion coefficient, m2 s-1 
dp particle diameter, m 
dp0 initial particle diameter, m 
kAds  adsorption rate constant, kg s-1 
KAds adsorption coefficient, m3 kg-1 
kw  wetting constant, kg-1 
m weight of dissolved caffeine, kg 
m weight of the sample, kg 
m0 initial weight of the sample, kg 
Q flow rate, m3 s-1 
r(t) dissolution rate, kg m-3 s-1 
t time, s 
V volume of dissolution vessel, m3 
δHL hydrodynamic layer thickness, m 
ρ density, kg m-3 
μ specific dissolution rate, s-1 
2. Materials and methods 
2.1. Model substance 
Anhydrous caffeine was used as a model substance. Powdered, wet-granulated and two sieve fractions 
of compacted caffeine were included in the study. 
Powdered caffeine was obtained by courtesy of Zentiva Inc. (Czech Republic). Particle size, measured 
by optical microscopy image analysis (reported as Maximum Feret Diameter) was < 10 μm for 70 % of 
particles and < 45 μm for 95 % of particles. 
Wet-granulated caffeine was obtained by granulating caffeine (50 % wt.), Avicel PH 101 
microcrystalline cellulose (50 % wt.) and Povidon 30 (1.7 % wt.) in a laboratory high shear mixer vertical 
granulator Glatt VG 25. Purified water was used as a moisturizer. After drying, the granulate was sieved 
through a 1.25 mm sieve. Particle size distribution of the granulated caffeine can be found in fig. 1a.  
Compacted caffeine was obtained by blending caffeine (50 % wt.) and Avicel PH 101 (50 % wt.) and 
compressing the mixture into 16 mm lenticular tablets (average tablets hardness approx. 40 N), then 
processing tablets on Frewitt sieving mill using a 1,25 mm sieve. Particle size distribution of the 
compacted caffeine can be found in Fig. 1b. Only fractions containing particle sizes of 75 – 125 μm and  
425 – 1000 μm were further used in dissolution experiments.  
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2.2. Dissolution testing of final dosage form 
Dissolution testing of final dosage forms was performed in USP 2 dissolution apparatus AT7 Smart 
(Sotax AG, Switzerland) according to USP guidelines [10]. Samples were dissolved in 0.1N hydrochloric 
acid (37 °C). 
In the first set of experiments gelatin capsules (20.5 mm in length) were filled with 5, 10 and 15 mg of 
caffeine in all 3 different forms. The capsules were supplied with a spiral sinker to ensure them to sink on 
the bottom of the vessel. The rotation speed of the paddle was 25 rpm. 
In the second set of experiments each form of caffeine was compressed using a semiautomatic press 
ML-105 (Phar service, Czech Republic). Applying the pressing force of 15 kN, tablets of 10 mm in 
diameter and weight ca. 0,38 g were gained. These tablets were tested in the USP 2 apparatus with paddle 
rotation speed of 49 rpm, so that the hydrodynamic conditions were similar to the experiment with 
capsules. Calculations of the agitation rate were performed according to reference [11]. 
In both cases, samples were taken in the following times from the beginning of the experiment: 1, 3, 5, 
7, 10, 15, 20, 30, 40 and 50 minute. 
The caffeine concentration was measured immediately after sampling using UV-VIS 
spectrophotometer UV mini 1240 (Shimadzu, Japan). The value of absorbance was read in its maximum, 
272 nm. A calibration curve was used for determining the concentration in the samples from absorbance. 
It consisted of 8 points, was linear (R2 > 0.9999) and the intercept was not significantly different from 
zero (B ≈ 0.0002). 
The dependence of concentration on time was then used for the calculation of the specific dissolution 
rate μ according to eq. 1 
 
Fig. 1. Particle size distribution of granulated (a) and compacted (b) caffeine obtained by sieve analysis 
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where V is the vessel volume, m0 is the initial weight of the sample, mt is the weight of dissolved 
caffeine and dc/dt is the change of concentration over time. 
2.3. Dissolution testing of powdered, granulated and compacted forms 
The dissolution tests of the powdered, granulated and compacted forms were carried out using USP 4 
dissolution apparatus Sotax Dissotest CE with reciprocating pump Sotax CY 1, (Sotax, Switzerland), 
equipped with the cell for powders and granulates 12 mm in diameter. The open-loop configuration was 
used according to USP [10]. The dissolution apparatus and the flask with dissolution medium (0.1 N HCl) 
were both immersed in 37 °C water bath. 
Samples were taken at the cell outlet tubing. First thirteen samples were withdrawn uniformly in 10 
seconds intervals. Additional samples were taken in the following times: 2.5 minute, and 3, 4, 5, 7, 10, 
15, 20 minutes. Afterwards all samples were analyzed using a high performance liquid chromatography, 
which consisted of LC Prominence (Shimadzu, Japan) with PDA detector on LiChrospher 60, RP-select 
B, 5 μm column (Merck). Solution of dibasic ammonium phosphate in water (pH = 3.5 ± 0.1) and 
methanol (1.5:1) was used as a mobile phase (isocratic 1 ml/min). The injection volume of the sample 
was 2 μl.  
The concentration was used for calculation of the dissolution rate r(t) according to eq. 2 
 
V
Qctr  )(  (2) 
 
where Q is the flow rate of the dissolution medium. 
The dissolution rate was then used for the calculation of the amount of dissolved caffeine mt (eq. 3) 
and specific dissolution rate (eq. 4) 
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3. Results and discussion 
3.1. Dissolution of final dosage form 
Results of the dissolution experiments with the final dosage forms are represented as data points in 
fig. 2. It is important to note that primary information of both apparatuses is concentration over time. 
However, concentration in USP 2 apparatus increases as caffeine accumulates in the vessel. Contrarily, 
concentration decreases in open-loop USP 4 arrangement as caffeine is flooded out of the cell. Because of 
that, the concentration of both apparatus was expressed as relative amount of dissolved caffeine. Such 
expression does not cause problems for paddle apparatus as it is given by the simple relative comparison 
of maximum and actual concentration. For a flow-through cell, the amount of dissolved caffeine must be 
calculated by the integration of the dissolution rate (eq. 3) which entails an integration error. 
The resulted data points from the experiment with the final dosage forms were obtained as the average 
of two (tablets) or three (capsules) independent measurements. It is obvious there are differences in 
release profiles related to the dosage form type as well as to the granulation method used.  
The dissolution profiles of the capsules with different caffeine forms were very similar (fig. 2a). From 
the detail of first ten minutes can be noticed that powdered caffeine dissolved slowest due to residual air 
in the capsule and strong adhesive forces between powder particles. Both of these effects caused that 
caffeine was not dispersed in the entire volume of the vessel and it stayed on the bottom of the vessel in 
clusters. On the contrary, the agglomerated forms dispersed relatively well; hence they dissolved faster 
than the powdered form. The comparison of the agglomerated forms is not too definite. The granulated 
caffeine dissolved faster in the very beginning of the experiment due to a larger effective surface area. 
Lately, it dissolved slower comparing to the compacted caffeine, due to stronger inhibition of the caffeine 
release caused by excipients (discussed later). 
The dissolution profiles of tablets were strongly influenced by their disintegration (fig. 2b). While the 
content of the capsule was rapidly dispersed after breaking the dissolution medium into the capsule, 
gradual disintegration is to occur in the case of the tablets. Thus, mainly the strength of disintegrants was 
Fig. 2. Caffeine release from capsules (a) and tablets (b); powdered (triangles) and granulated (circles) caffeine, compacted caffeine 
of 75 – 125 μm particles (empty squares) and compacted caffeine of 425 – 1000 μm particles (filled squares) 
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Fig. 3. (a) caffeine release from agglomerates; (b) time dependence of the specific dissolution rate of caffeine in agglomerates 
responsible for the beginning of the dissolution profiles of the tablets. Due to this fact, the powdered 
caffeine, being the form without any excipients, dissolved slowest and the compacted caffeine did slightly 
better than the granulated one in the beginning of the experiment. After the complete disintegration of the 
tablets, individual particles were then responsible for the shape of the dissolution profiles. Consequently 
the powdered caffeine, as the form with the largest effective surface dissolved fastest and granulated 
caffeine slightly better than the compacted one. Surprisingly, the dosage forms based on agglomerates did 
not release the entire amount of caffeine after 50 minutes. Therefore one experiment was extended to 150 
minutes, but even after the added time caffeine was not completely dissolved. Such behavior pointed out 
the possibility of the caffeine adsorption to microcrystalline cellulose.  
When comparing the profiles of the capsules and individual particles originated from the tablets, the 
differences were observed also. Therefore, we acknowledged the compression influenced the dissolution 
behavior substantially, but the mechanistic explanation is beyond the scope of this study. Instead, 
following USP 4 experiments were designed to establish, whether the dosage form dissolution behavior 
can be assessed upon tests, carried out with the agglomerates. 
3.2. Dissolution of agglomerates 
Results of the dissolution experiments with the agglomerates are represented as data points in fig 3. 
The data points were obtained as the average of two independent measurements. One of the biggest 
advantages of flow-through cell apparatus, that is the amount of obtained data in the short period of time, 
can be noticed at first glance in this figure. However the dependence of caffeine release from the 
agglomerates on time (fig 3a) does not provide much more information than plots in the fig. 2, or more 
precisely they show relative changes of the total caffeine concentration in the system. Therefore we 
introduced the specific dissolution rate (eq. 4), which shows the behavior of a unit amount of dissolved 
substance, and thus is very useful for comparing the individual forms. 
The data points in the figure 3b shows values of specific the dissolution rate. The lines represent possible 
fitting with the equations below considering different processes, which can be responsible for the shape of 
the dissolution profiles. ERA software [12] was used for fitting the equations to experimental data.  
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The powdered caffeine dissolution was characterized by eq. 5
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where D is the diffusion coefficient of caffeine, δHL is the diffusion layer thickness, A is the surface 
of particles, m is the actual weight of the sample and Cs is the concentration of the saturated solution. 
This equation represents dissolution of an ideal mixture with monodisperse spherical particles. The 
specific dissolution rate grows to infinity in this case, due to increasing surface/volume ratio. The 
experimental data follows this equation until approx. 95% of caffeine is dissolved. Following decrease is 
probably due to an integration error. 
 In the case of the agglomerates (excluding the fraction of the compacted caffeine with smaller 
particles) a slow decrease of the specific rate was observed during their dissolution. This was due to the 
content of excipients, which inhibit the caffeine release. We proposed two mechanisms to explain this 
inhibition effect (1). There is a barrier in the form of the excipient matrix which resists diffusion together 
with a hydrodynamic layer (2). Additionally, caffeine is adsorbed to the surface of excipients, so that its 
release is inhibited and it does not have to be completely dissolved in a solvent.  
By adding these two mechanisms in eq. 5 we obtained eq. 6 which characterizes dissolving of the 
agglomerated forms: 
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where dp and dp0 are the actual and initial particle diameter, respectively. Def  is the effective diffusion 
coefficient of caffeine characterizing the resistance to diffusion, kAds is the rate of adsorption and KAds is 
the adsorption coefficient.  
The experimental data fitted quite well to proposed mathematical characterization so we assumed that 
the processes occurred within the dissolution testing. 
During the experiment with the smaller particles of the compacted caffeine we observed that the 
particles in the sample were not dispersed immediately in the beginning of the experiment. Instead of that 
they hold together, contained in a “bubble”, forming after the medium flows into the cell, for several 
seconds and fell apart progressively. This is also reflected by the increase of the specific rate in fig. 3a. 
Consequently, the eq. 6 was extended with a term characterizing the wetting of the sample to 
accommodate for its effect and eq. 7 was obtained: 
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where kw is a constant characterizing wetting of the sample. The rate of wetting was certainly involved 
in the dissolution of all forms, but our observations and dissolution profiles both confirmed that this effect 
is significant only in the sample of the small compacts, as larger particles have lower buoyancy and fewer 
tendencies to contain air among them.  
3.3. Comparison of dissolution profiles of agglomerates and final dosage forms 
The introduction of the specific dissolution rate was very useful also for the comparison of the 
dissolution profiles of the agglomerates and final dosage forms. But it could not be used as time-related 
due to differences in a period that was necessary for dissolving the formulations. While more than 30 
minutes was necessary for the caffeine release of 95 % from the tablets and capsules, less than 3 minutes 
was necessary for the release of the same relative amount from the agglomerates. This was mainly due to 
different hydrodynamic conditions in the apparatuses. Therefore we related the specific dissolution rate to 
the amount of dissolved caffeine (fig.4 and 5). 
A very good qualitative agreement can be observed comparing dissolution profiles of agglomerates in 
the capsules and in the flow-through cell in fig. 4a and 4b respectively. Basically these figures differ only 
in the scale of the y-axis, which shows that only hydrodynamic conditions are responsible for the 
differences. It may be assumed then that, simple correlation using dimensionless numbers and the theory 
of similarity can be used for indentifying the quantitative difference in the experiments. However, this 
cannot be used generally, since the apparatus have completely different agitation systems.  
Even bigger differences, due to the hydrodynamic conditions in the apparatuses, were observed in the 
experiments with the tablets and crushed agglomerates, fig. 5a and 5b respectively. Moreover, there are 
Fig. 4. Dependence of caffeine specific dissolution rate on its dissolved amount for capsules in USP 2 (a) and agglomerates in 
USP 4 (b) 
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other differences caused by the disintegration phase of the tablet, which do not occur within the 
experiment with the compressed and crushed agglomerates. Tablets must not necessarily disintegrate to 
particles which they originated from. Furthermore, these particles appeared also in the upper parts of the 
vessel where is completely different hydrodynamic environment, comparing with lower parts. Because of 
facts mentioned above, the relation between the data of the tablets and corresponding agglomerates seems 
more complicated than that between the capsules and corresponding agglomerates where it approximates 
to linear. To prove the relation between the tablets and corresponding agglomerates exists, we calculated 
Spearman`s correlation coefficient significant at 0.05 level:  
Granulated caffeine: ρ = 0.770 
Compacted caffeine (75 – 125 μm): ρ = 0.762 
Compacted caffeine (425 – 1000 μm): ρ = 0.857 
Hence it was shown, there is a correlation between the tablets and corresponding agglomerates and it 
can be assumed that the dissolution behavior can be characterized quantitatively as well as qualitatively. 
Also the fig. 5 shows, there is the same relative order among different granulates, as well as the shape or 
flatness of the specific rate curve is roughly the same. 
When comparing the dissolution profiles of the capsules and tablets (or their corresponding 
agglomerates), fig. 4 and 5. The effect of compression can be observed. The caffeine release rate from the 
granulate increased due to compression, so that it exceeded the release from the compacted form which 
contrarily decreased. 
4. Conclusions 
By comparing the dissolution profiles of the capsules and tablets with the dissolution profiles of the 
agglomerates and compressed and crushed agglomerates respectively, it was shown that the dissolution 
behavior of the final dosage forms was influenced by the same effects as their precursors. Therefore we 
propose that agglomerates can be used for assessing the dissolution behavior of potential candidates on a 
final dosage form. Thus there is no need for preparing a final dosage form, from several alternative 
formulations, which is time consuming and it can bring errors in the comparison of different formulations.  
Fig. 5. Dependence of caffeine specific dissolution rate on its dissolved amount for tablets in USP 2 (a) and compressed and crushed 
agglomerates in USP 4(b) 
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Moreover, dissolution studies of agglomerates and introducing the specific dissolution rate provided us 
very detailed information about each form of caffeine. Thus we proposed mathematical characterizations 
of processes which can be responsible for the dissolution behavior of a particulate caffeine form. These 
characterizations should be helpful in the future quantifying the relationship between agglomerates and 
dosage forms disolution behavior. 
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